4.5 Article

Reduced muscle strength in patients with long-COVID-19 syndrome is mediated by limb muscle mass

Related references

Note: Only part of the references are listed.
Letter Critical Care Medicine

Decreased Fatty Acid Oxidation and Altered Lactate Production during Exercise in Patients with Post-acute COVID-19 Syndrome

Esther de Boer et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Review Microbiology

Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms

Qing Han et al.

Summary: Emerging evidence suggests that COVID-19 survivors may experience persistent symptoms for at least 12 months, including fatigue, dyspnea, arthromyalgia, depression, anxiety, memory loss, concentration difficulties, and insomnia. Female patients and those with more severe initial illness are more likely to suffer from long-term sequelae after one year.

PATHOGENS (2022)

Review Nutrition & Dietetics

Unraveling Muscle Impairment Associated With COVID-19 and the Role of 3D Culture in Its Investigation

Maria Luiza G. A. Seixas et al.

Summary: COVID-19's impact on the respiratory system has been extensively studied, but the evidence for its effects on skeletal muscle is not strong enough to effectively treat and prevent muscle impairment. Studies have shown that COVID-19 is associated with skeletal muscle damage, including conditions like sarcopenia and myalgia. Understanding the interaction between COVID-19 and skeletal muscle, as well as exploring new cell culture techniques, is crucial for improving treatment plans for infected patients.

FRONTIERS IN NUTRITION (2022)

Article Medicine, General & Internal

Extrapulmonary features of post-COVID-19 patients: muscle function, physical activity, mood, and sleep quality

Aylin Tanriverdi et al.

Summary: Extrapulmonary features are adversely affected in a substantial proportion of post-COVID-19 patients who recovered from mild and moderate disease severity in the mid-term. Comprehensive assessment and appropriate intervention strategies should be considered for non-severe post-COVID-19 patients.

IRISH JOURNAL OF MEDICAL SCIENCE (2022)

Article Clinical Neurology

Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: Evidence of skeletal muscle histopathology

Eva K. Hejbol et al.

Summary: This study explores the histopathological changes in patients with post-COVID-19 fatigue and finds a wide variety of changes in skeletal muscles, including muscle fiber atrophy, mitochondrial changes, inflammation, and capillary injury. These changes may contribute to the fatigue experienced by patients, partly due to reduced energy supply. Even mild acute infections could lead to long-term myopathy.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Biochemistry & Molecular Biology

Symptoms and risk factors for long COVID in non-hospitalized adults

Anuradhaa Subramanian et al.

Summary: A retrospective analysis of primary care records in the United Kingdom reveals individual symptoms associated with SARS-CoV-2 infections, which persisted for 12 weeks or more after infection, as well as risk factors associated with developing long COVID.

NATURE MEDICINE (2022)

Article Medicine, Research & Experimental

Resistance training and clinical status in patients with postdischarge symptoms after COVID-19: protocol for a randomized controlled crossover trial The EXER-COVID Crossover Study

Robinson Ramirez-Velez et al.

Summary: This study aims to evaluate the effects of supervised resistance training on immunological parameters, physical condition, inflammatory profile, and persistent perceived symptoms in patients with postdischarge symptoms after COVID-19. The results will provide valuable insights for guiding exercise rehabilitation guidelines for patients recovering from COVID-19.

TRIALS (2022)

Article Immunology

Medium-Term Outcomes in Severely to Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Nandan Gautam et al.

Summary: A study found that a significant proportion of severely ill COVID-19 patients still experience symptoms such as breathlessness, fatigue, pain, reduced mobility, depression, and decreased quality of life 4-7 months after disease onset, with symptomatic patients having more residual chest radiographic and LFT abnormalities.

CLINICAL INFECTIOUS DISEASES (2022)

Letter Rheumatology

Myositis as a manifestation of SARS-CoV-2

Maxime Beydon et al.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Cell Biology

Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19

Saima Ajaz et al.

Summary: Patients with COVID-19 show compromised mitochondrial function, metabolic alterations, increased inflammation, and severity of symptoms. Targeting mitochondrial metabolic pathways may help define novel treatment strategies for COVID-19.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2021)

Review Physiology

Effect of exercise on myosteatosis in adults: a systematic review and meta-analysis

Robinson Ramirez-Velez et al.

Summary: Muscle tissue typically contains only small amounts of adipose tissue, and exercise can reduce lipid infiltration and increase muscle attenuation coefficient. Age and intervention duration did not significantly affect the effects of exercise on lipid infiltration tissue and muscle radiation attenuation.

JOURNAL OF APPLIED PHYSIOLOGY (2021)

Article Anesthesiology

Muscle weakness, functional capacities and recovery for COVID-19 ICU survivors

Clement Medrinal et al.

Summary: The majority of COVID-19 ICU survivors experienced acquired limb muscle weakness. One-fourth of patients had both limb and respiratory muscle weakness. 44% of patients with limb weakness still had severely limited function in walking one month post weaning.

BMC ANESTHESIOLOGY (2021)

Review Virology

18F-FDG-PET Imaging for Post-COVID-19 Brain and Skeletal Muscle Alterations

Thorsten Rudroff et al.

Summary: Scientific evidence on the subacute and long-term effects of COVID-19 caused by SARS-CoV-2 infection is increasing. The infection is systemic and involves multiple organs, leading to diverse complications and long-term consequences. While a significant proportion of patients experience neurological manifestations, the exact brain and skeletal muscle changes from SARS-CoV-2 infection remain largely unknown.

VIRUSES-BASEL (2021)

Article Physiology

Skeletal Muscle Wasting and Function Impairment in Intensive Care Patients With Severe COVID-19

Mario Chueire de Andrade-Junior et al.

Summary: This study found that muscle wasting and decreased muscle strength occur early and rapidly in intensive care patients with severe COVID-19 during the first 10 days of ICU stay, despite improvements in mobility and respiratory functions. However, none of the patients returned to normal levels in terms of muscle function.

FRONTIERS IN PHYSIOLOGY (2021)

Letter Medicine, General & Internal

Sequelae in Adults at 6 Months After COVID-19 Infection

Jennifer K. Logue et al.

JAMA NETWORK OPEN (2021)

Article Physiology

Impact of presymptomatic COVID-19 on vascular and skeletal muscle function: a case study

Joel D. Trinity et al.

Summary: This case study reveals the presymptomatic impact of COVID-19 on vascular and skeletal muscle function in a young woman. Prior to COVID-19 diagnosis, significant reductions in vascular, skeletal muscle, and mitochondrial function were observed along with an elevation in IL-10 levels. This integrative case study indicates that the presymptomatic impact of COVID-19 is widespread and may help elucidate the acute and long-term sequelae of this disease.

JOURNAL OF APPLIED PHYSIOLOGY (2021)

Article Sport Sciences

Angiotensin-Converting Enzyme 2 (SARS-CoV-2 receptor) expression in human skeletal muscle

Mario Perez-Valera et al.

Summary: This study found that women have higher levels of ACE2 protein expression in their skeletal muscles compared to men, and this sexual dimorphism is mainly attributed to differences in body fat percentage and cardiorespiratory fitness. The body fat percentage is the main predictor of the variability in ACE2 protein expression in human skeletal muscle.

SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS (2021)

Article Geriatrics & Gerontology

Severe loss of mechanical efficiency in COVID-19 patients

Eulogio Pleguezuelos et al.

Summary: The study identified decreased muscle efficiency in patients with COVID-19, similar to those with COPD and IHD, suggesting resistance training should be considered during early rehabilitation.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2021)

Article Parasitology

The predictive role of biomarkers for mortality in COVID-19 patients

A. Savrun et al.

Summary: This study aimed to determine the relationship between COVID-19 severity and mortality rate by analyzing various biomarkers. The results showed that levels of certain biomarkers, such as D-dimer, ferritin, lactate, AST, ALT, LDH, urea, creatinine, APTT, and INR, were significantly higher in patients who tested positive for COVID-19. It is recommended to closely monitor the changes in neutrophil, lymphocyte, CRP, and ferritin levels during treatment to assess effectiveness and determine next steps.

TROPICAL BIOMEDICINE (2021)

Review Geriatrics & Gerontology

Post-COVID-19 acute sarcopenia: physiopathology and management

Karolina Piotrowicz et al.

Summary: This review examines the pathophysiology and management of acute sarcopenia in relation to SARS-CoV-2 infection, emphasizing the impact on in-hospital prognosis and post-COVID-19 functional deterioration. Multiple factors, including pre-infection medical condition, influence the individual outcome of COVID-19 in terms of muscle mass and functional loss.

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2021)

Article Cardiac & Cardiovascular Systems

Delphi consensus recommendations on how to provide cardiovascular rehabilitation in the COVID-19 era

Marco Ambrosetti et al.

Summary: This Delphi consensus by 28 experts from the European Association of Preventive Cardiology provides initial recommendations on how cardiovascular rehabilitation facilities should modulate their activities during the ongoing COVID-19 pandemic. Consensus was reached on 58 statements, mainly focusing on referral, core components, and structure of CR activities suitable for managing cardiac COVID-19 patients. Experts suggested maintaining usual activities for traditional patient groups referred to CR during the pandemic, with minimal downgrading of intervention for COVID-19 patients as comorbidities.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)

Review Infectious Diseases

COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review

Sonia Poenaru et al.

Summary: COVID-19 can lead to a prolonged convalescence with chronic symptoms resembling those of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), although more research is needed to confirm any link between the two conditions.

THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE (2021)

Article Rehabilitation

Muscle Strength and Physical Performance in Patients Without Previous Disabilities Recovering From COVID-19 Pneumonia

Mara Paneroni et al.

Summary: This cross-sectional study evaluated skeletal muscle strength and physical performance in hospitalized patients recovering from COVID-19 pneumonia. The study found a high prevalence of impairment in muscle strength and physical performance, suggesting the need for rehabilitation programs after discharge.

AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2021)

Article Orthopedics

Musculoskeletal Consequences of COVID-19

Nathaniel P. Disser et al.

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2020)

Review Medicine, General & Internal

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review

W. Joost Wiersinga et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Letter Critical Care Medicine

Intensive care unit acquired muscle weakness in COVID-19 patients

Nathalie Van Aerde et al.

INTENSIVE CARE MEDICINE (2020)

Review Medicine, General & Internal

Neurological Consequences of 2019-nCoV Infection: A Comprehensive Literature Review

Dua Azim et al.

CUREUS JOURNAL OF MEDICAL SCIENCE (2020)

Review Endocrinology & Metabolism

Mechanisms for fiber-type specificity of skeletal muscle atrophy

Yichen Wang et al.

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2013)

Review Biochemistry & Molecular Biology

Muscle type and fiber type specificity in muscle wasting

Stefano Ciciliot et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)

Review Nutrition & Dietetics

What is dynapenia?

Brian C. Clark et al.

NUTRITION (2012)

Article Endocrinology & Metabolism

Dual-Energy X-Ray Absorptiometry for Quantification of Visceral Fat

Sanjiv Kaul et al.

OBESITY (2012)

Article Geriatrics & Gerontology

Sarcopenia: European consensus on definition and diagnosis

Alfonso J. Cruz-Jentoft et al.

AGE AND AGEING (2010)

Article Nutrition & Dietetics

Metabolic consequences of muscle disuse atrophy

TP Stein et al.

JOURNAL OF NUTRITION (2005)

Article Rehabilitation

The impact of severe acute respiratory syndrome on the physical profile and quality of life

HMC Lau et al.

ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2005)

Article Sport Sciences

International physical activity questionnaire:: 12-country reliability and validity

CL Craig et al.

MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2003)

Review Sport Sciences

Muscle strength testing - Use of normalisation for body size

S Jaric

SPORTS MEDICINE (2002)